ATE196848T1 - Verwendung eines mittels zur stabilisierung des fötus zur vorbeugung von durch infektionen verursachte fehlgeburten - Google Patents

Verwendung eines mittels zur stabilisierung des fötus zur vorbeugung von durch infektionen verursachte fehlgeburten

Info

Publication number
ATE196848T1
ATE196848T1 AT95304766T AT95304766T ATE196848T1 AT E196848 T1 ATE196848 T1 AT E196848T1 AT 95304766 T AT95304766 T AT 95304766T AT 95304766 T AT95304766 T AT 95304766T AT E196848 T1 ATE196848 T1 AT E196848T1
Authority
AT
Austria
Prior art keywords
fetus
iga
fixation
prevent
infection
Prior art date
Application number
AT95304766T
Other languages
English (en)
Inventor
Hisako Yasui
Jun Otsuka
Junko Kiyoshima
Original Assignee
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk filed Critical Yakult Honsha Kk
Application granted granted Critical
Publication of ATE196848T1 publication Critical patent/ATE196848T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Materials For Medical Uses (AREA)
AT95304766T 1994-07-12 1995-07-07 Verwendung eines mittels zur stabilisierung des fötus zur vorbeugung von durch infektionen verursachte fehlgeburten ATE196848T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6181963A JPH0827011A (ja) 1994-07-12 1994-07-12 胎児定着増強剤及び母動物用食

Publications (1)

Publication Number Publication Date
ATE196848T1 true ATE196848T1 (de) 2000-10-15

Family

ID=16109935

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95304766T ATE196848T1 (de) 1994-07-12 1995-07-07 Verwendung eines mittels zur stabilisierung des fötus zur vorbeugung von durch infektionen verursachte fehlgeburten

Country Status (7)

Country Link
US (1) US5910305A (de)
EP (1) EP0692256B1 (de)
JP (1) JPH0827011A (de)
KR (1) KR960003737A (de)
AT (1) ATE196848T1 (de)
AU (1) AU701770B2 (de)
DE (1) DE69519060T2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0827011A (ja) * 1994-07-12 1996-01-30 Yakult Honsha Co Ltd 胎児定着増強剤及び母動物用食
CN1384711A (zh) * 1999-10-28 2002-12-11 株式会社养乐多本社 含双歧杆菌的发酵食品
TWI578969B (zh) * 2015-03-20 2017-04-21 王家壽 動物之人工授孕及診療裝置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2645554B2 (ja) * 1986-12-29 1997-08-25 株式会社 ミドリ十字 流産・死産防止剤
JPH07106142B2 (ja) * 1989-04-21 1995-11-15 株式会社ヤクルト本社 ＩｇＡ誘導能を有するビフィドバクテリウム・ロンガム又はビフィドバクテリウム・ブレーベ
JP2968374B2 (ja) * 1991-05-16 1999-10-25 株式会社ヤクルト本社 ＩｇＡ産生促進剤
JP3163171B2 (ja) * 1992-07-15 2001-05-08 森永乳業株式会社 ＩｇＡ産生促進剤
JPH0827011A (ja) * 1994-07-12 1996-01-30 Yakult Honsha Co Ltd 胎児定着増強剤及び母動物用食

Also Published As

Publication number Publication date
DE69519060T2 (de) 2001-06-21
KR960003737A (ko) 1996-02-23
EP0692256A1 (de) 1996-01-17
JPH0827011A (ja) 1996-01-30
DE69519060D1 (de) 2000-11-16
EP0692256B1 (de) 2000-10-11
AU2490695A (en) 1996-01-25
US5910305A (en) 1999-06-08
AU701770B2 (en) 1999-02-04

Similar Documents

Publication Publication Date Title
DE68926828D1 (de) Verfahren zur Potenzierung einer Immunreaktion sowie die dazugehörigen Mittel
DE3854741T3 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
DE69215722D1 (de) Verstärker zur Ultraschalltherapie von Erkrankungen sowie diesen enthaltende flüssige Arzneimittelzusammensetzungen
ATE319474T1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
DE69332518T2 (de) Unterdrückung von autoimmunkrankheiten durch antigene in wartestellung
NZ547776A (en) Modified vaccinia virus ankara for protecting an animal against an antigen or self-protein
HK1045941B (zh) 過敏反應的治療
IL82459A0 (en) Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems
MY122216A (en) New vaccine and method of use
ATE196848T1 (de) Verwendung eines mittels zur stabilisierung des fötus zur vorbeugung von durch infektionen verursachte fehlgeburten
DE3780814D1 (de) Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden.
JPS6468320A (en) Remedy for psychotic disease or like and therapeutical solution
DE69623652D1 (de) Formulierung zur peptidfreisetzung
ATE197545T1 (de) Verwendung von aspirin zur herstellung eines arzneimittels zur verbesserung fer blutperfusion des uterus
Singh et al. Ovulation and fertility after PRID, PRID+ GnRH and GnRH in anestrous buffaloes
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
RU2002133839A (ru) Способ хирургического лечения воспалительно-деструктивных заболеваний пародонта
NZ510885A (en) Use of selamectin to treat parasitic infections in infants by administering it to the female parent before and ending after parturition
CA2122604A1 (en) Uses of aloe products, e.g. acemannan, in the treatment of diseases requiring intervention of the immune system for cure
WO2003099322A3 (en) Il-11 derivatives and therapeutic uses thereof
Wang et al. Effect of LH on superovulation of Swamp buffalo in China
Hethcote A vaccination model for an endemic disease with maternal antibodies in infants.
HOARE VESICULAR EXANTHEMA OF HORSES AND CATTLE
Fox By HENRY MACCORMAC, CBE, MD
Snijman Gangrenous stomatitis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties